Abstract:To promote drug accumulation and cell-killing ability at tumor tissue, we have prepared a stepwise targeted drug delivery system that can remain stealthy and long-circulating in the blood vessels, improve drug retention at extracellular stimuli, enhance cellular uptake through special targeting ligands, and then achieve rapid drug release to improve toxicity to tumor cells at intracellular stimuli. Herein, galactose-grafted, ultra-pH-sensitive drug carriers (POEAd-g-LA-DOX micelles), which could respond to both extracellular and intracellular pH, and combine with galactose-receptors in cell membrane, were constructed by a facile method, therefore achieving: (i) remaining stable at pH 7.4; (ii) responding to tumoral extracellular pH following gradually larger nanoparticles (NPs); (iii) conjugating receptors in the cell membrane of liver cancer through surface galactose-ligands of micelles; (iv) being sensitive to tumoral intracellular pH following further swelling for rapid drug release. In vitro cytotoxicity and cellular uptake measurement showed that POEAd-g-LA20-DOX micelle was more easily internalized and more toxic effect on tumor cells than free DOX. Moreover, in vivo biodistribution and tumor inhibition examinations demonstrated that POEAd-g-LA20-DOX formulation had more superior efficacy to significantly enhance drug accumulation in tumor, and then restrain tumor growth while decreasing drug concentration in heart.Statement of SignificanceChemotherapeutic efficacy is limited by poor tumor selectivity, which also causes severe toxicity in normal tissues and organs, although many targeted drug delivery systems have been developed by passive targeting strategies or active targeting strategies with specific targeting ligands in recent years. Herein, galactose-grafted, ultra-pH-sensitive, ortho ester-based drug carriers, which can respond to both extra cellular and intracellular pH, and target to galactose-receptors in cell membrane, have been successfully constructed by facile method, therefore achieving stepwise targeting to microenvironment of liver cancer and then enhancing drug accumulation and tumor inhibition. The strategy of designing dual-stimuli responsive copolymers can be potentially useful, and extrapolated to synthesizing other categories of highly labile drug carriers in a range of biomedical applications. (c) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell–Targeting Effect

Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).

Liver Targeting of Galactosylated Liposome-Polycation-dna Complexes

[Liver Targeting of Cationic Liposomes Modified with Soybean-Derived Sterylglucoside in Vitro].

Construction of Efficacious Hepatoma-Targeted Nanomicelles Non-Covalently Functionalized with Galactose for Drug Delivery

Synthesis of Multivalent Galactosides as Targeting Ligand for Gene Delivery

Lactobionic acid coupled liposomes: an innovative strategy for targeting hepatocellular carcinoma

Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol

Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer

Development of glycyrrhetinic acid ligand-functionalized liposomes for targeting hepatocellular carcinoma: synthesis, preparation, characterization, and evaluation

Biotin and glucose dual-targeting, ligand-modified liposomes promote breast tumor-specific drug delivery

Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma

Development of Asialoglycoprotein-Mediated Hepatocyte-Targeting Antitumor Prodrugs Triggered by Glutathione

Biotin and Glucose Co-Modified Multi-Targeting Liposomes for Efficient Delivery of Chemotherapeutics for the Treatment of Glioma

Sialic Acid-Modified O-GlcNAc Transferase Inhibitor Liposome Presents Antitumor Effect in Hepatocellular Carcinoma

Liver-targeted Resveratrol Liposome

Stepwise Targeted Drug Delivery to Liver Cancer Cells for Enhanced Therapeutic Efficacy by Galactose-Grafted, Ultra-Ph-sensitive Micelles.

Stepwise targeting and responsive lipid-coated nanoparticles for enhanced tumor cell sensitivity and hepatocellular carcinoma therapy

Synthesis of Multivalent Galactosides with High Affinity for the Hepatic Asialoglycoprotein Receptor

Synthesis of a Novel Multivalent Galactoside with High Hepatocyte Targeting for Gene Delivery

Preparation of Liposomes Surface-modified with Glycyrrhetinic Acid Targeting to Hepatocytes